Found: 34
Select item for more details and to access through your institution.
Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use: summary.
- Published in:
- Vox Sanguinis, 2017, v. 112, n. 7, p. 680, doi. 10.1111/vox.12522
- By:
- Publication type:
- Article
Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use.
- Published in:
- Vox Sanguinis, 2017, v. 112, n. 7, p. e48, doi. 10.1111/vox.12523
- By:
- Publication type:
- Article
Relevance of flow cytometric enumeration of post-thaw leucocytes: influence of temperature during cell staining on viable cell recovery.
- Published in:
- Vox Sanguinis, 2016, v. 111, n. 2, p. 187, doi. 10.1111/vox.12398
- By:
- Publication type:
- Article
Administration of Prednisolone intravenously or Dexamethason orally in random donors reveals equal results in granulocyte collection: a single centre experience.
- Published in:
- Vox Sanguinis, 2012, v. 103, n. 1, p. 75, doi. 10.1111/j.1423-0410.2011.01567.x
- By:
- Publication type:
- Article
Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow).
- Published in:
- Vox Sanguinis, 2011, v. 101, n. 3, p. 255, doi. 10.1111/j.1423-0410.2011.01471.x
- By:
- Publication type:
- Article
Transfusion policy in ABO-incompatible allogeneic stem cell transplantation.
- Published in:
- Vox Sanguinis, 2010, v. 98, n. 3p2, p. 455, doi. 10.1111/j.1423-0410.2009.01292.x
- By:
- Publication type:
- Article
Transfusion policy in ABO-incompatible allogeneic stem cell transplantation.
- Published in:
- Vox Sanguinis, 2010, v. 98, n. 3b, p. 455, doi. 10.1111/j.1423-0410.2009.01292.x
- By:
- Publication type:
- Article
Red blood units collected from bone marrow harvests after mononuclear cell selection qualify for autologous use.
- Published in:
- Vox Sanguinis, 2010, v. 98, n. 3a, p. e284, doi. 10.1111/j.1423-0410.2009.01300.x
- By:
- Publication type:
- Article
Apheresis products of the Amicus™ and the AS.TEC 204® cell separators are comparable with regard to dendritic cells derived from the mononuclear cell collection.
- Published in:
- Vox Sanguinis, 2007, v. 92, n. 1, p. 37, doi. 10.1111/j.1423-0410.2006.00859.x
- By:
- Publication type:
- Article
Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases.
- Published in:
- Bone Marrow Transplantation, 2000, v. 25, n. 2, p. 223, doi. 10.1038/sj.bmt.1702124
- By:
- Publication type:
- Article
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimal timing of PBPC harvest.
- Published in:
- 2001
- By:
- Publication type:
- journal article
PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Increase in endogenous thrombopoietin in healthy donors after automated plateletpheresis.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Fibrin sealant produced by the CryoSeal® FS System: product chemistry, material properties and possible preparation in the autologous preoperative setting.
- Published in:
- Vox Sanguinis, 2004, v. 86, n. 4, p. 257, doi. 10.1111/j.0042-9007.2004.00516.x
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 220, doi. 10.1038/bmt.2012.119
- By:
- Publication type:
- Article
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1046, doi. 10.1038/bmt.2011.216
- By:
- Publication type:
- Article
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 7, p. 1003, doi. 10.1038/bmt.2011.199
- By:
- Publication type:
- Article
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 1, p. 18, doi. 10.1038/bmt.2011.9
- By:
- Publication type:
- Article
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 356, doi. 10.1038/bmt.2010.128
- By:
- Publication type:
- Article
Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study.
- Published in:
- Bone Marrow Transplantation, 2009, v. 43, n. 5, p. 357, doi. 10.1038/bmt.2008.335
- By:
- Publication type:
- Article
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb<sup>®</sup> immunoadsorption.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 10, p. 1015, doi. 10.1038/sj.bmt.1704264
- By:
- Publication type:
- Article
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2002, v. 30, n. 9, p. 619, doi. 10.1038/sj.bmt.1703677
- By:
- Publication type:
- Article
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26).
- Published in:
- 2000
- By:
- Publication type:
- journal article
Mechanisms underlying acquired von Willebrand syndrome associated with an IgM paraprotein.
- Published in:
- European Journal of Clinical Investigation, 2009, v. 39, n. 9, p. 833, doi. 10.1111/j.1365-2362.2009.02177.x
- By:
- Publication type:
- Article
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
- Published in:
- European Journal of Clinical Investigation, 2008, v. 38, n. 12, p. 945, doi. 10.1111/j.1365-2362.2008.02041.x
- By:
- Publication type:
- Article
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 4, p. 746, doi. 10.1038/leu.2011.257
- By:
- Publication type:
- Article
Therapeutic apheresis in hematopoietic cell transplantation.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
SAFETY AND EFFICACY OF TISAGENLECLEUCEL PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: UPDATED ANALYSIS OF THE PHASE 1B PORTIA STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.179_2880
- By:
- Publication type:
- Article
EPSTEIN‐BARR VIRUS‐DRIVEN DISEASES: A MULTINATIONAL, MULTICOHORT, OPEN‐LABEL PHASE 2 STUDY TO ASSESS THE EFFICACY AND SAFETY OF TABELECLEUCEL USING AN ADAPTIVE STUDY DESIGN.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.170_2880
- By:
- Publication type:
- Article
PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 560, doi. 10.1002/hon.7_2632
- By:
- Publication type:
- Article
PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 560, doi. 10.1002/hon.7_2632
- By:
- Publication type:
- Article